STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more

RegulatoryReplimune melanoma drugPositive

AI Analysis

Summary

A federal judge dismissed an antitrust lawsuit filed by a compound pharmacy against Eli Lilly and Novo Nordisk. The article briefly mentions Replimune's melanoma drug among other topics.

Outcome Details

Federal judge dismissed antitrust lawsuit against Eli Lilly and Novo Nordisk filed by compound pharmacy

Importance:3/10

Sentiment:

0.30

antitrustlegalcompound pharmacymelanoma

Related Companies

$LLY $NVO

Read the original article

Published by STAT News on August 7, 2026 1:18 PM

Read Original